GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 20.89
-0.91 (-4.17%)
At close: May 12, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 8.54 billion as of May 12, 2026. Its market cap has increased by 82.35% in one year.
Market Cap
8.54B
Enterprise Value
7.72B
Revenue
830.61M
Ranking
n/a
PE Ratio
52.12
Stock Price
20.89
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 8.54B, an increase of 12.64%. That is a compound annual growth rate of 2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 8.54B | 35.66% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 9.56B |
| Daan Gene | 9.32B |
| Aurisco Pharmaceutical | 9.23B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.94B |
| Sino Biological,Inc. | 8.78B |
| Zhejiang Ausun Pharmaceutical | 8.38B |
| Bio-Thera Solutions | 8.30B |
| Nanjing Vazyme Biotech | 8.10B |